A detailed history of Spotlight Asset Group, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Spotlight Asset Group, Inc. holds 82,100 shares of TGTX stock, worth $2.43 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
82,100
Previous 82,100 -0.0%
Holding current value
$2.43 Million
Previous $1.25 Million 16.99%
% of portfolio
1.05%
Previous 0.92%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.02 - $21.3 $40,362 - $66,030
3,100 Added 3.92%
82,100 $1.25 Million
Q3 2023

Nov 14, 2023

BUY
$8.36 - $26.5 $33,440 - $106,000
4,000 Added 5.33%
79,000 $660,000
Q1 2021

Apr 07, 2021

BUY
$41.61 - $54.3 $832,200 - $1.09 Million
20,000 Added 36.36%
75,000 $3.62 Million
Q4 2019

Apr 13, 2020

BUY
$5.1 - $11.2 $280,500 - $616,000
55,000 New
55,000 $576,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Spotlight Asset Group, Inc. Portfolio

Follow Spotlight Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spotlight Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spotlight Asset Group, Inc. with notifications on news.